Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights
Frontiers in Oncology · 13.03.2024 · 14
DOI: 10.3389/fonc.2024.1365614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 13.03.2024. Verfasst von Namsoo Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Aplastic anemia (AA), characterized by hematopoietic stem cell deficiency, can evolve into different hematologic malignancies. Our understanding of the genetic basis and mechanisms of this progression remains limited.
Methods
We retrospectively studied 9 acquired AA patients who later developed hematologic malignancies. Data encompassed clinical, laboratory, karyotype, and next-generation sequencing (NGS) information. We explored chromosomal alterations and mutation profiles to uncover genetic changes underlying the transition.
Results
Nine AA patients developed myelodysplastic syndrome (seven patients), acute myeloid leukemia (one patient), or chronic myelomonocytic leukemia (one patient). Among eight patients with karyotype results at secondary malignancy diagnosis, monosomy 7 was detected in three. Trisomy 1, der(1;7), del(6q), trisomy 8, and del(12p) were detected in one patient each. Among three patients with NGS results at secondary malignancy diagnosis, KMT2C mutation was detected in two patients. Acquisition of a PTPN11 mutation was observed in one patient who underwent follow-up NGS testing during progression from chronic myelomonocytic leukemia to acute myeloid leukemia.
Conclusion
This study highlights the genetic dynamics in the progression from AA to hematologic malignancy. Monosomy 7’s prevalence and the occurrence of PTPN11 mutations suggest predictive and prognostic significance. Clonal evolution underscores the complexity of disease progression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Dxome Co. Ltd., Seongnam-si, Gyeonggi-do, Republic of Korea.
- Department of Pediatric Hematology-Oncology, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.
Zitieren
APA
Kim, N., Choi, Y. J., Lee, S. T., Choi, J. R., Lyu, C. J., Shin, S., & Cheong, J. W. (2024). Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1365614
Vancouver
Kim N, Choi YJ, Lee ST, Choi JR, Lyu CJ, Shin S, et al. Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1365614
BibTeX
@article{Kim2024,
author = {Kim, Namsoo and Choi, Yu Jeong and Lee, Seung-Tae and Choi, Jong Rak and Lyu, Chuhl Joo and Shin, Saeam and Cheong, June-Won},
title = {Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights},
journal = {Frontiers in Oncology},
year = {2024},
volume = {14},
doi = {10.3389/fonc.2024.1365614}
}
EUVIMED